The number of SMN2 copies serves as the primary genetic modifier of SMA severity: higher copy numbers are associated with increased production of functional SMN protein and correspondingly milder disease phenotypes [10]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.